Letter: Breast cancer associated with administration of spironolactone.
D000368:Aged; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000139:chemically induced*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D011956:Receptors, Cell Surface; D013148:Spironolactone / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use
D011956:Receptors, Cell Surface; D013148:Spironolactone